About
Bernie Rudnick is the retired CEO of Virion Therapeutics, LLC, which he co-founded with Dr. Andy Luber, Dr. Hildegund Ertl, and the Wistar Institute to develop checkpoint inhibitor-based vaccines targeting virally induced cancers and chronic infectious disease. He is the founder and managing partner of CapGenic Advisors, LLC, and has held C-level roles at Immunomic Therapeutics and Atrin Pharmaceuticals, where he currently serves as a director. Rudnick co-founded Mid-Atlantic Bio Angels and an entrepreneurial program (MADV) at the Fox School of Business, and has held multiple commercial and non-profit board positions along with advisory roles for clients including Mitsui, DuPont, and McKesson Bioservices.
Founder at virion
Intro paths
In turn, Bernie can intro founders to virion's investors below.
virion's investors · 2
Co-founders at virion
Experience
- Virion TherapeuticsRetired CEO, Virion Therapeutics, LLCcurrent2020 — present
- CapGenic Advisors, LLCManaging Partnercurrent2004 — present
- CapGenic Advisors, LLCSemi-retired, multiple board positions2020
- Mid Atlantic Bio AngelsCo-Foundercurrent2012 — presentNew York City Metropolitan Area
- Mid Atlantic Bio Angelsco-founder2012 — 2016
- Keiretsu Forum PhiladelphiaAngel Investorcurrent2005 — presentMid Adlantic Region (originally joined in SW, now in Mid'Atlantic
- Atrin PharmaceuticalsFormer Chief Financial Officer - Currently Directorcurrent2015 — presentDoylestown, PA Greater Philadelphia Area
- Viirion Therapeutics, LLCCEO - Director2018 — 2020Greater Philadelphia
- Immunomic TherapeuticsFormer Chief Financial Officer - Director2007 — 2015Hershey, Pennsylvania, Rockville, MD
- Minority Angel Investor NetworkAngel Investor2005 — 2014Ben Franklin Technology Partners, Philadelphia
Skills & more
+10 more
Strategic PartnershipsDeal SourcingCommercializationExecutive ManagementCorporate FinanceInvestmentsLifesciencesBiotechnologyStrategyLeadershipFrom Bernie's professional profile.
Frequently asked questions
- Who is Bernie Rudnick?
- Bernie Rudnick is the retired CEO of Virion Therapeutics, LLC, which he co-founded with Dr. Andy Luber, Dr. Hildegund Ertl, and the Wistar Institute to develop checkpoint inhibitor-based vaccines targeting virally induced cancers and chronic infectious disease. He is the founder and managing partner of CapGenic Advisors, LLC, and has held C-level roles at Immunomic Therapeutics and Atrin Pharmaceuticals, where he currently serves as a director. Rudnick co-founded Mid-Atlantic Bio Angels and an entrepreneurial program (MADV) at the Fox School of Business, and has held multiple commercial and non-profit board positions along with advisory roles for clients including Mitsui, DuPont, and McKesson Bioservices.
- Where does Bernie Rudnick work?
- Bernie Rudnick is Founder of virion.
- What companies did Bernie Rudnick found?
- Bernie Rudnick founded virion.
- Where did Bernie Rudnick go to school?
- Bernie Rudnick studied at Pennsylvania State University (Bachelor of Science (BS), Biochemistry); Northwood University (MA, Business Administration, Management and Operations).
